Physician profile
John A Pirolli
NPI 1639124456
$4,594.79
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,091 · 2020: $1,687 · 2021: $438 · 2022: $223 · 2023: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,029.42 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $788.97 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $408.19 | 2019-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.82 | 2019-2023 | Jardiance, Tradjenta |
| Amarin Pharma, INC. | $282.37 | 2019-2021 | |
| Glaxosmithkline, LLC. | $258.42 | 2019-2023 | Shingrix, Arexvy |
| Pfizer INC. | $257.77 | 2019-2023 | |
| Amgen INC. | $233.49 | 2019-2023 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $158.10 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.81 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $113.58 | 2019-2020 | |
| Allergan, INC. | $92.90 | 2019-2020 | |
| Abbvie INC. | $84.60 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $73.22 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.56 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $54.28 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $46.52 | 2019 | |
| Sanofi-Aventis U.S. LLC | $42.54 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $41.13 | 2019 | |
| Eisai INC. | $39.83 | 2019 | |
| Mannkind Corporation | $28.10 | 2019 | |
| Exact Sciences Corporation | $23.15 | 2023 | Cologuard Collection Kit |
| Gebauer Company | $19.84 | 2020 | |
| Ibsa Pharma INC. | $14.64 | 2019 | |
| Currax Pharmaceuticals LLC | $12.33 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pirolli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.